Some ethnic minorities could be twice as likely as white and Native American people to prefer counseling and prayer to medication for treating depression, according to a national Internet survey.
When is an herbal tea a safe and effective sleep aid, and when is that same tea a risky pharmaceutical choice? Health care professionals face such questions daily, and a University of Arkansas researcher cautions that they may need to acquire advanced clinical skills in order to assure patient safety.
A key aspect of how embryos create the cells which secrete insulin is revealed in a new study published tomorrow (18 May) in the Journal of Biological Chemistry.
Scientists have found evidence that the cox-2 inhibitor celecoxib, a common pain reliever used to treat arthritis, may offer a new way to reduce the risk of the most common cause of brain damage in babies born prematurely.
Until recently, nonsteroidal anti-inflammatory drugs (NSAIDs) like aspirin and celecoxib (sold as Celebrex), were being hailed as promising cancer prevention drugs.
The American College of Physicians (ACP) this morning commended Marcy Kaptur and Steven C. LaTourette, members of Congress, for their bipartisan sponsorship of the Health Coverage, Affordability, Responsibility and Equity (CARE) Act.
In the first study of its kind to evaluate how smoking restrictions in the workplace and at home affect health status, researchers at the Mailman School of Public Health found that nonsmokers who live under both a total household and total workplace smoking ban are over two and a half times more likely to report better health than those without smoking bans.
A Web-based program that provides prostate cancer patients with information about different treatment approaches may make deciding which path to follow a little easier, Medical College of Georgia researchers say.
Can you imagine an archer trying to improve her accuracy by practicing blindfolded, never seeing how close she was to hitting her target, never getting any information to help correct her aim”
Scientists have shown that a single 2.5mg dose of vitamin D may be enough to boost the immune system to fight against tuberculosis (TB) and similar bacteria for at least 6 weeks.